Covid-19 - Clinical Trials Arena

mRNA licensing agreements surge 800% amid GSK lawsuits

Eve Thomas — Fri, 18 Oct 2024 19:14:09 +0000

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are facing lawsuits.

The post mRNA licensing agreements surge 800% amid GSK lawsuits appeared first on Clinical Trials Arena.

NIH selects Emergex’s T cell vaccine for trials under Project NextGen

Vishnu Priyan — Thu, 03 Oct 2024 10:23:21 +0000

The NIH unit NIAID has selected Emergex Vaccines' T cell-priming vaccine for Betacoronaviruses for clinical trials under Project NextGen.

The post NIH selects Emergex’s T cell vaccine for trials under Project NextGen appeared first on Clinical Trials Arena.

Moderna blamed after children offered £1,500 to take part in Covid-19 trial

Jenna Philpott — Thu, 26 Sep 2024 14:43:07 +0000

An NHS paediatrician sent a WhatsApp message offering children and parents £1,500 to take part in Moderna’s Phase III NextCOVE trial.

The post Moderna blamed after children offered £1,500 to take part in Covid-19 trial appeared first on Clinical Trials Arena.

Testosterone could influence men’s immune response to Covid-19

GlobalData Healthcare — Tue, 10 Sep 2024 14:58:09 +0000

According to WHO, there have been over 760 million cases of Covid-19 globally since December 2019. Interestingly, men and women have been shown to react to Covid-19 infection differently.

The post Testosterone could influence men’s immune response to Covid-19 appeared first on Clinical Trials Arena.

As mpox spreads, ‘national governments have a moral responsibility to help’

Eve Thomas — Thu, 05 Sep 2024 16:38:27 +0000

Representatives of the WHO and the IFRC called for international cooperation to tackle the current mpox outbreak.

The post As mpox spreads, ‘national governments have a moral responsibility to help’ appeared first on Clinical Trials Arena.

What is mpox and how big of a threat is it?

Eve Thomas — Tue, 27 Aug 2024 11:01:46 +0000

Declared a PHEIC by the WHO, an mpox outbreak in the DRC is posing a threat to human health.

The post What is mpox and how big of a threat is it? appeared first on Clinical Trials Arena.

Entos and Aegis announce dosing of first subject in Covid-19 vaccine trial

Vishnu Priyan — Wed, 07 Aug 2024 08:56:15 +0000

Entos Pharmaceuticals and Aegis Life dosed first subject in the Phase I/II trial of Covigenix VAX-002 as a booster vaccine for Covid-19.

The post Entos and Aegis announce dosing of first subject in Covid-19 vaccine trial appeared first on Clinical Trials Arena.

AB Science touts positive Phase II Covid-19 data for masitinib

Jenna Philpott — Mon, 08 Jul 2024 15:34:35 +0000

AB Science aimed to enrol 200 patients in the trial, but the study stopped enrolling after 95 patients due to recruitment challenges.

The post AB Science touts positive Phase II Covid-19 data for masitinib appeared first on Clinical Trials Arena.

NIH announces start of subject enrolment for nasal Covid-19 vaccine trial

Vishnu Priyan — Tue, 02 Jul 2024 08:47:41 +0000

The US National Institutes of Health (NIH) has announced the start of subject enrolment for a Phase I clinical trial of MPV/S-2P.

The post NIH announces start of subject enrolment for nasal Covid-19 vaccine trial appeared first on Clinical Trials Arena.

CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial

Vishnu Priyan — Fri, 14 Jun 2024 10:16:19 +0000

CyanVac has received federal funding to conduct a Phase IIb comparative clinical trial of its intranasal Covid-19 vaccine candidate, CVXGA.

The post CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial appeared first on Clinical Trials Arena.